News
He stated that the episode of the last six months showed just how brutally efficient the price discovery process is, in any ...
Amid the sultry summer months, a few signs of fall become apparent, such as the appearance of school supplies on stores ...
Novavax's growth relies on Sanofi royalties and COVID/flu vaccines, lacking innovation and clear catalysts. Click here to ...
DOJ filed the statement of interest in United States District Court for the case Children’s Health Defense et al. v. Washington Post et al., which lists among its defendants the BBC, Reuters, the ...
Shares of Moderna (NASDAQ:MRNA) have been long forgotten about since its demand for COVID shots fell off a cliff more than ...
1d
Stocktwits on MSNGSK Stock Gains As Flu Vaccine Rollout Begins And US Recovers From Most Severe Season In 15 YearsShares of GSK rose on Thursday after the company announced it had begun shipping its seasonal flu vaccines, Fluarix and ...
A CDC advisory panel vote to recommend against use of seasonal influenza vaccines containing small amounts of thimerosal ...
1d
InvestorsHub on MSNTonix Pharmaceuticals Shares Climb on Encouraging TNX-801 Vaccine ResultsTonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) saw its stock rise 2% after unveiling new preclinical findings for its ...
Secretary Kennedy’s latest maneuver seeks to expand vaccine injury lawsuits, echoing a precarious time in US history when ...
Phatisa sells Deltamune to Vaxxinova, expanding animal health capabilities across Africa and strengthening regional vaccine production and innovation.
In this week’s edition of InnovationRx, we look at Immuneering’s slow-and-steady approach to cancer fighting, litigation over ...
Merck & Co., Inc. (NYSE:MRK) is one of the 10 best defensive stocks to buy in a volatile market. On July 2, UBS reiterated a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results